{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:15:28Z","timestamp":1793042128706,"version":"4.5.0"},"reference-count":61,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4,19]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Expansion of PD-1+ CD3\u2212CD56hiCD16-ve NK cells and PD-L1+ monocytes\/macrophages is more prominent in cHL than DLBCL. PD-1 blockade reverses the immune evasion mediated by the interaction of PD-1+ NK cells and PD-L1+ monocytes\/macrophages.<\/jats:p>","DOI":"10.1182\/blood-2017-07-796342","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T13:55:13Z","timestamp":1518702913000},"page":"1809-1819","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":294,"title":["Immune evasion via PD-1\/PD-L1 on NK cells and monocyte\/macrophages is more prominent in Hodgkin lymphoma than DLBCL"],"prefix":"10.1182","volume":"131","author":[{"given":"Frank","family":"Vari","sequence":"first","affiliation":[{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Arpon","sequence":"additional","affiliation":[{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Keane","sequence":"additional","affiliation":[{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"},{"name":"Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Hertzberg","sequence":"additional","affiliation":[{"name":"Haematology, Prince of Wales Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Talaulikar","sequence":"additional","affiliation":[{"name":"Canberra Hospital, Canberra, ACT, Australia;"},{"name":"Australian National University Medical School, Acton, ACT, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Jain","sequence":"additional","affiliation":[{"name":"Canberra Hospital, Canberra, ACT, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Cui","sequence":"additional","affiliation":[{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Han","sequence":"additional","affiliation":[{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Tobin","sequence":"additional","affiliation":[{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"},{"name":"Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bird","sequence":"additional","affiliation":[{"name":"Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Cross","sequence":"additional","affiliation":[{"name":"Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Gould","sequence":"additional","affiliation":[{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"},{"name":"Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Birch","sequence":"additional","affiliation":[{"name":"Department of Pathology, Princess Alexandra Hospital, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-5393","authenticated-orcid":false,"given":"Maher K.","family":"Gandhi","sequence":"additional","affiliation":[{"name":"University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia;"},{"name":"Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111903562049700_B1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111903562049700_B2","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S1470-2045(16)30167-X","article-title":"Nivolumab for classical Hodgkin\u2019s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial","volume":"17","author":"Younes","year":"2016","journal-title":"Lancet Oncol"},{"issue":"31","key":"2019111903562049700_B3","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2016.67.3467","article-title":"Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure","volume":"34","author":"Armand","year":"2016","journal-title":"J Clin Oncol"},{"issue":"19","key":"2019111903562049700_B4","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","article-title":"Phase II study of the efficacy and safety of pembrolizumab for relapsed\/refractory classic Hodgkin lymphoma","volume":"35","author":"Chen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"23","key":"2019111903562049700_B5","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","article-title":"Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study","volume":"34","author":"Lesokhin","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111903562049700_B6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2017-07-740993","article-title":"PD-1 expression and clinical PD-1 blockade in B-cell lymphomas","volume":"131","author":"Xu-Monette","year":"2018","journal-title":"Blood. Blood"},{"issue":"6","key":"2019111903562049700_B7","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis"},{"issue":"4","key":"2019111903562049700_B8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrclinonc.2016.168","article-title":"PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas","volume":"14","author":"Goodman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2019111903562049700_B9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrclinonc.2015.187","article-title":"Novel immunotherapies in lymphoid malignancies","volume":"13","author":"Batlevi","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"2019111903562049700_B10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"issue":"11","key":"2019111903562049700_B11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"2019111903562049700_B12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"issue":"9244","key":"2019111903562049700_B13","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"2019111903562049700_B14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/bcp.12318","article-title":"A new frontier in haematology - combining pharmacokinetic with pharmacodynamic factors to improve choice and dose of drug","volume":"78","author":"Arpon","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"2019111903562049700_B15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"issue":"10","key":"2019111903562049700_B16","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"issue":"13","key":"2019111903562049700_B17","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2019111903562049700_B18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2011.39.9881","article-title":"Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome","volume":"31","author":"Greaves","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111903562049700_B19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"issue":"6769","key":"2019111903562049700_B20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"22","key":"2019111903562049700_B21","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111903562049700_B22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2010-05-283820","article-title":"Immunosuppressive CD14+HLA-DR(low)\/- monocytes in B-cell non-Hodgkin lymphoma","volume":"117","author":"Lin","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111903562049700_B23","doi-asserted-by":"crossref","first-page":"e1393599","DOI":"10.1080\/2162402X.2017.1393599","article-title":"B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity","volume":"7","author":"McKee","year":"2017","journal-title":"OncoImmunology"},{"issue":"5","key":"2019111903562049700_B24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3324\/haematol.2015.139493","article-title":"Role of the tumor microenvironment in mature B-cell lymphoid malignancies","volume":"101","author":"Fowler","year":"2016","journal-title":"Haematologica"},{"issue":"8","key":"2019111903562049700_B25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2019111903562049700_B26","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S2352-3026(15)00150-7","article-title":"Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study","volume":"2","author":"Keane","year":"2015","journal-title":"Lancet Haematol"},{"issue":"23","key":"2019111903562049700_B27","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J Clin Oncol"},{"issue":"19","key":"2019111903562049700_B28","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Kiyasu","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2019111903562049700_B29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/1078-0432.CCR-13-1024","article-title":"Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma","volume":"20","author":"Jones","year":"2014","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"2","key":"2019111903562049700_B30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/cei.12716","article-title":"The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma","volume":"183","author":"Jones","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2019111903562049700_B31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3324\/haematol.2016.154039","article-title":"Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14","volume":"102","author":"Hertzberg","year":"2017","journal-title":"Haematologica"},{"issue":"13","key":"2019111903562049700_B32","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1182\/blood-2010-03-274076","article-title":"Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders","volume":"116","author":"Jones","year":"2010","journal-title":"Blood"},{"issue":"1-2","key":"2019111903562049700_B33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods"},{"issue":"5","key":"2019111903562049700_B34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jcyt.2015.03.611","article-title":"Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy","volume":"17","author":"Granzin","year":"2015","journal-title":"Cytotherapy"},{"issue":"1-2","key":"2019111903562049700_B35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2007.05.013","article-title":"A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay","volume":"325","author":"Kim","year":"2007","journal-title":"J Immunol Methods"},{"issue":"13","key":"2019111903562049700_B36","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2010-02-271874","article-title":"The PD-1\/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody","volume":"116","author":"Benson","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111903562049700_B37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A comprehensive transcriptional portrait of human cancer cell lines","volume":"33","author":"Klijn","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"7","key":"2019111903562049700_B38","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3324\/haematol.2011.054254","article-title":"Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model","volume":"97","author":"Swift","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"2019111903562049700_B39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/sji.12162","article-title":"An optimized protocol for human M2 macrophages using M-CSF and IL-4\/IL-10\/TGF-\u03b2 yields a dominant immunosuppressive phenotype","volume":"79","author":"Mia","year":"2014","journal-title":"Scand J Immunol"},{"key":"2019111903562049700_B40","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb1419s84","article-title":"Visualization of microscopy-based spectral imaging data from multi-label tissue sections","volume-title":"Curr Protoc Mol Biol","author":"Mansfield","year":"2008"},{"issue":"1","key":"2019111903562049700_B41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40425-015-0091-z","article-title":"Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma","volume":"3","author":"Feng","year":"2015","journal-title":"J Immunother Cancer"},{"issue":"7","key":"2019111903562049700_B42","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1158\/1078-0432.CCR-16-1576","article-title":"The T-cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive B-cell lymphoma","volume":"23","author":"Keane","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2019111903562049700_B43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111903562049700_B44","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2019111903562049700_B45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/(SICI)1097-0215(19981123)78:5<533::AID-IJC1>3.0.CO;2-2","article-title":"A distinct distribution of natural killer cell subgroups in human tissues and blood","volume":"78","author":"M\u00f6ller","year":"1998","journal-title":"Int J Cancer"},{"issue":"7","key":"2019111903562049700_B46","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J Immunol"},{"issue":"8","key":"2019111903562049700_B47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cyto.a.22302","article-title":"Human NK cell receptors\/markers: a tool to analyze NK cell development, subsets and function","volume":"83","author":"Montaldo","year":"2013","journal-title":"Cytometry A"},{"issue":"7655","key":"2019111903562049700_B48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"issue":"15","key":"2019111903562049700_B49","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2009-06-227934","article-title":"CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells","volume":"115","author":"Baessler","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111903562049700_B50","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2006-04-015164","article-title":"Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients","volume":"108","author":"Gandhi","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2019111903562049700_B51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.172.1.88","article-title":"The IL-12 signature: NK cell terminal CD56+high stage and effector functions","volume":"172","author":"Loza","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"2019111903562049700_B52","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.166.11.6477","article-title":"Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire","volume":"166","author":"Campbell","year":"2001","journal-title":"J Immunol"},{"issue":"13","key":"2019111903562049700_B53","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function","volume":"108","author":"Della Chiesa","year":"2006","journal-title":"Blood"},{"issue":"21","key":"2019111903562049700_B54","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2012.44.2137","article-title":"Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation","volume":"31","author":"Kiaii","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111903562049700_B55","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood-2015-01-622936","article-title":"PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia","volume":"126","author":"McClanahan","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2019111903562049700_B56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"2019111903562049700_B57","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2326","article-title":"Inhibitory B7-family molecules in the tumour microenvironment","volume":"8","author":"Zou","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"7528","key":"2019111903562049700_B58","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"issue":"20","key":"2019111903562049700_B59","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1182\/blood-2011-07-365825","article-title":"Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells","volume":"118","author":"Obermajer","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111903562049700_B60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hon.2019","article-title":"Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells","volume":"31","author":"Tadmor","year":"2013","journal-title":"Hematol Oncol"},{"issue":"4","key":"2019111903562049700_B61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ajh.23398","article-title":"CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy","volume":"88","author":"Keane","year":"2013","journal-title":"Am J Hematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/16\/1809\/1467877\/blood796342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/16\/1809\/1467877\/blood796342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:56:58Z","timestamp":1574135818000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/131\/16\/1809\/36851\/Immune-evasion-via-PD1PDL1-on-NK-cells-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":61,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,4,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-07-796342","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732682886.793552704","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,19]]}}}